Clinical trials
Completed Observational Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
367 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 6 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 7 |
| 2005 | 7 |
| 2006 | 18 |
| 2007 | 19 |
| 2008 | 16 |
| 2009 | 14 |
| 2010 | 18 |
| 2011 | 23 |
| 2012 | 15 |
| 2013 | 9 |
| 2014 | 14 |
| 2015 | 20 |
| 2016 | 27 |
| 2017 | 22 |
| 2018 | 14 |
| 2019 | 17 |
| 2020 | 24 |
| 2021 | 16 |
| 2022 | 20 |
| 2023 | 9 |
| 2024 | 12 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 367 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 17 |
| University of Pittsburgh | 12 |
| ViiV Healthcare | 8 |
| Pfizer | 7 |
| AbbVie (prior sponsor, Abbott) | 5 |
| Celgene | 4 |
| Imperial College London | 4 |
| Rigshospitalet, Denmark | 4 |
| University of North Carolina, Chapel Hill | 4 |
| University of Ulm | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 367 |
| Sepsis | 53 |
| Inflammation | 27 |
| COVID-19 | 22 |
| Disease | 14 |
| Acquired Immunodeficiency Syndrome | 13 |
| Shock, Septic | 13 |
| Critical Illness | 12 |
| Pneumonia | 12 |
| Heart Failure | 10 |
Trials
Showing 1 to 25 of 367. Each trial links to its page on Pharma Observatory.
267 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.